These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 5418266)

  • 21. Use of antiplatelet agents and anticoagulants in post-myocardial infarction.
    Fiore LD; Deykin D
    Cardiol Clin; 1994 Aug; 12(3):451-76. PubMed ID: 7805079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical effects of anticoagulants in suspected acute myocardial infarction. Use of anticoagulants in suspected acute myocardial infarction in Europe varies.
    Ketley D; Woods KL
    BMJ; 1997 Jan; 314(7075):223. PubMed ID: 9022454
    [No Abstract]   [Full Text] [Related]  

  • 23. Management of acute myocardial infarction with special reference to rest and anticoagulants.
    Lal HB; Caroli RK; Sengupta D; Basumalik SN; Khan MA; Malik RN
    J Assoc Physicians India; 1966 Dec; 14(12):695-707. PubMed ID: 5980925
    [No Abstract]   [Full Text] [Related]  

  • 24. Coronary mortality and living standard. II. Coffee, tea, cocoa, alcohol and tobacco.
    Brummer P
    Acta Med Scand; 1969; 186(1-2):61-3. PubMed ID: 5807646
    [No Abstract]   [Full Text] [Related]  

  • 25. [Results of the physical rehabilitation of myocardial infarct patients in the convalescence phase].
    Kavtaradze VG; Litanishvili VB; Vatsadze TG; Svanishvili RA; Nizharadze NK
    Vopr Kurortol Fizioter Lech Fiz Kult; 1983; (3):10-3. PubMed ID: 6623970
    [No Abstract]   [Full Text] [Related]  

  • 26. [Patient assessment before initiating a cardiac rehabilitation program after an acute myocardial infarct--the role of the stress test].
    Mendes M
    Rev Port Cardiol; 1995; 14(7-8):553-8. PubMed ID: 7669330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secondary prevention in myocardial infarction survivors.
    Circulation; 1982 Jan; 65(1):216A-219A. PubMed ID: 7053284
    [No Abstract]   [Full Text] [Related]  

  • 28. [Risk factors, prognosis, treatment and rehabilitation in myocardial infarct].
    Kühns K; Wettich JE; Samwer KF
    Landarzt; 1967 Aug; 43(24):1133-43. PubMed ID: 5591693
    [No Abstract]   [Full Text] [Related]  

  • 29. Risk of stroke during long-term anticoagulant therapy in patients after myocardial infarction.
    Azar AJ; Koudstaal PJ; Wintzen AR; van Bergen PF; Jonker JJ; Deckers JW
    Ann Neurol; 1996 Mar; 39(3):301-7. PubMed ID: 8602748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A critical appraisal of anticoagulants for short-term and long-term use in the management of myocardial infarction and systemic arterial embolism. II.
    FRIEDBERG CK
    N Y State J Med; 1958 Apr; 58(8):1303-8. PubMed ID: 13541715
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of anti-coagulants in myocardial infarction.
    Thanabalasundram RS
    Ceylon Med J; 1968 Jun; 13(2):77-9. PubMed ID: 5715194
    [No Abstract]   [Full Text] [Related]  

  • 32. [Influence of different frequencies of acupuncture on therapeutic effect in patients with cerebral infarction at convalescence].
    Qian XP; Xu F; Song JL; Zhao JH
    Zhongguo Zhen Jiu; 2009 Jan; 29(1):7-9. PubMed ID: 19186713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anticoagulants or thrombocyte aggregation inhibitors in the prevention of recurrent heart infarction?].
    Volger E; Theiss W
    MMW Munch Med Wochenschr; 1983 Apr; 125(14):285-8. PubMed ID: 6406866
    [No Abstract]   [Full Text] [Related]  

  • 34. [A multimodality method for the rehabilitation of myocardial infarct patients with a hyperkinetic type of hemodynamics during convalescence].
    Novikov SA
    Vopr Kurortol Fizioter Lech Fiz Kult; 1994; (6):8-10. PubMed ID: 7762214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. E.P.S.I.M., the French oral anticoagulant--aspirin trial in post-myocardial infarction patients: design, organization and quality control procedures.
    Boissel JP; Leizorovicz A; Schbath J; Destors JM; Gillet J
    Scand J Haematol Suppl; 1981; 38():47-72. PubMed ID: 7038857
    [No Abstract]   [Full Text] [Related]  

  • 36. [Platelet antiaggregants or anticoagulants in the secondary prevention after myocardial infarct].
    Di Pasquale G; Ottani F; Ceré E; Biancoli S; Sassone B; Lombardi A
    Recenti Prog Med; 1998 Oct; 89(10):514-9. PubMed ID: 9842255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of physical factors in the rehabilitative treatment of myocardial infarct patients in the convalescence phase].
    Sorokina EI
    Vopr Kurortol Fizioter Lech Fiz Kult; 1983; (3):1-7. PubMed ID: 6623969
    [No Abstract]   [Full Text] [Related]  

  • 38. Truck driving and risk of myocardial infarction.
    Malinauskiene V
    Przegl Lek; 2003; 60 Suppl 6():89-90. PubMed ID: 15106466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood fibrinolytic activity in myocardial infarction.
    Bhandari MM; Jain SR; Chhabra ML; Sepaha GC
    Indian Heart J; 1968 Oct; 20(4):361-8. PubMed ID: 5740734
    [No Abstract]   [Full Text] [Related]  

  • 40. [Anticoagulants and thrombocyte aggregation inhibitors in the treatment of heart infarct. A survey].
    Spitzer W; Durst OE; Lang E
    Fortschr Med; 1983 Jan; 101(1-2):22-30. PubMed ID: 6826125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.